Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes

Annals of Hematology

Volumn 79, Issue 1, 2000, Pages 20-29

  Schmetzer, Helga M ^b   Poleck, B ^c   Duell, T ^c   Gerhartz, H H ^c   Mittermuller J ^a  

^a Institute of Hematology   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NONE

Author keywords

Clonality; Cytogenetic; Myelodysplasia; Southern blot analysis

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN J CHAIN; INTERLEUKIN 3; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ARTICLE; BONE MARROW; CHEMOTHERAPY; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLONE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DENSITOMETRY; DEVICE; DISEASE COURSE; DRUG RESPONSE; FEMALE; GENE REARRANGEMENT; HIGH RISK POPULATION; HUMAN; HUMAN CELL; KARYOTYPE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SOUTHERN BLOTTING; TRISOMY 8;

EID: 0034094094     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050004     Document Type: Article

References (41)

1. De Vita VT, Hellmann JS, Rosenberg SA (1997) Principles and practice of oncology. Lippincott-Raven, Philadelphia
2. Masey JA (1997) The myelodysplastic syndromes. Br J Biomed Sc 54:65-70
3. Lowenthal RM, Marsden KA (1997) Myelodysplastic syndromes. Int J Hematol 65:319-338
4. Miller JW, Kakizuka A, Frankel SR, Warrell JR, de Blasio A, Levine K, Evans RM, Dimitrovsky E (1992) Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A 89:2694-2702
5. Ganser A, Ottmann OG, Seipelt G, Lindemann A, Hess U, Geissler G, Maurer A, Frisch J, Schulz G, Mertelsmann R (1993) Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes. Leukemia 7:696-701
6. Gerhartz HH, Marcus R, Delmer A (1994) A randomized phase II study of low dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. Leukemia 8:16-23
7. Wijermanns PW, Krulder JW, Huijgens PC, Neve P (1997) Continuous infusion of low dose 5-aza-2′-deoxycytinide in elderly patients with high-risk myelodysplastic syndrome. Leukemia 11:19-23
8. Sanz G, Sanz M, Greenberg P (1998) Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica 83:358-368
9. Ohyashiki K, Ohyashiki JH, Iwabuchi A, Toyama K (1996) Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes. Leuk Lymphoma 23:409-415
10. Togama K, Ohyashiki K, Yoshida Y, Abe T (1993) Clinical implications of chromosomal abnormalities in 401 patients with MDS: a multicentric study in Japan. Leukemia 7:499-507
11. Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 73:248-254
12. Bernell P, Jacobsson B, Nordgren A, Hast R (1996) Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia 10:662-668
13. Fialkow PJ (1972) Use of genetic markers to study cellular origin of development of tumors in human females. Adv Cancer Res 15:191-226
14. Gale RE, Mein CA, Linch DC (1996) Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia 10:362-367
15. Lepelley P (1994) Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 8:1342-1349
16. Van der Lely N, Poddighe P, Wessels J (1995) Clonal analysis of progenitor cells by interphase cytogenetics in patients with acute myeloid leukemia and myelodysplasia. Leukemia 9:1167-1172
17. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA (1992) Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 81:346-352
18. Cheng GY, Kelleher CA, Miauchi J (1988) Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood 71:204-208
19. Schumacher HR, Shrit MA, Kowal-Vern A (1991) Acute leukemia and related entities. Arch Pathol Lab Med 115:331-337
20. Greaves MF (1982) "Target" cells, differentiation and clonal evolution: a "model" for understanding the biology of malignancy. In: Shaw MT (ed) Chronic granulocytic leukemia. Praeger, New York, p 15
21. Gerhartz HH, Schmetzer HM (1990) Detection of minimal residual disease in acute myeloid leukemia. Leukemia 4:508-516
22. Rothe G, Schmitz G (1996) Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 10:877-895
23. Seabright MA (1971) Rapid banding technique for human chromosomes. Lancet 2:971-972
24. Maniatis T, Fritsch E, Sambrook J (1982) Molecular cloning, a laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, NY
25. Takahashi N, Nakai S, Honjo T (1980) Cloning of human immunoglobulin μ gene and comparison with mouse μ gene. Nucleic Acids Res 8:5983-5991
26. Van den Elsen P, Shepley BA, Borst J, Coligan JE, Markham AF, Orkin S, Terhorst C (1984) Isolation of cDNA clones encoding the 2OK T3 glycoprotein of human T-cell receptor complex. Nature 312:413-418
27. Shtivelman E, Lifshitz B, Gale R, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550-554
28. Wong GC, Witek J, Temple PA, Wilkens KM, Leary AC, Luxemberg DP, Jones SS, Brown EC, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Henrick RM, Wang EA, Clark SC (1985) Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228:810-815
29. Nagata T, Masayuki T, Asano T, Kaziro Y, Yamazaki T, Yamamoto Y, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415-418
30. Otsuka T, Miyajima A, Brown N, Otsu K, Abrams J, Saeland S, Caux C, Malefijt R, Vries J, Meyerson P, Yokota K, Gemmel L, Rennick D, Lee F, Arai N, Arai K, Yokota T (1988) Isolation and characterization of an expressible cDNA encoding human IL-3. J Immunol 140:2288-2295
31. Morell P (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 7:1315-1323
32. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW (1993) Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy and clone expansion. Blood 81:1580-1585
33. Raskind WH, Tirumali N, Jacobson R (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 63:1318-1323
34. Schmetzer HM, Poleck B, Mittermueller J, Duell T, Wilmanns W, Gerhartz HH (1997) Clonality analysis as a tool to study the biology and response to therapy in myelodysplastic syndromes. Leukemia 11:660-666
35. Campana D, Ching-Hon P (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 85:1416-1434
36. Wright JJ, Poplack DG, Bakshi A, Reaman G, Cole D, Jansen JP, Korsmeyer SJ (1987) Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol 5:735-741
37. Raghavachar A, Bartram CR, Ganser A. Heil G, Kleihauer E, Kubanek B (1986) Acute undifferentiated leukemia: implication for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement. Blood 68:658-662
38. Hagemeijer A, Bolhuis RL, van Dongen JJ, Sizou W (1986) Simultaneous occurrence of acute monoblastic leukemia and an abnormal B-cell clone with both cell types characterized by specific cytogenetic and immunological markers. Scand J Haematol 36:484-491
39. MacDonald D, Jiang YZ, Swirsky D, Vulliamy T, Morilla R, Bungey J, Barrett AJ (1991) Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor. Br J Haematol 77:43-49
40. Schmetzer HM, Gerhartz HH (1993) Acute myeloid leukemia (AML) can be oligoclonal. Leukemia 7:1965-1970
41. Mittermüller J, Schmetzer H, Duell T, Gerhartz H, Wilmanns W (1996) IL-3-Gene and GM-CSF gene rearrangements in myelodysplasia (MDS) and acute leukemia (AL) with abnormalities of the chromosome 5q. Hematology 73 [Suppl 2]: 6 (abstract 23)